株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の冠動脈ステント市場:2017〜2021年

Global Coronary Stents Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 306306
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.79円で換算しております。
Back to Top
世界の冠動脈ステント市場:2017〜2021年 Global Coronary Stents Market 2017-2021
出版日: 2017年04月12日 ページ情報: 英文 70 Pages
概要

世界の冠動脈ステント市場は、2017〜2021年の間、5.61%のCAGRで拡大するとみられています。

当レポートでは、世界の冠動脈ステント市場の現状と将来的見通しについて調査し、今後の市場規模と成長率、市場動向、市場成長の課題、市場の機会と脅威、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 市場環境

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 製品別市場セグメンテーション

  • 薬剤溶出ステント(DES)市場
  • 生体吸収性ステント市場
  • ベアメタル溶出ステント(BMS)市場

第7章 エンドユーザー別市場セグメンテーション

  • 通院外科診療所(ASC)
  • 病院
  • 開業医院

第8章 地域別セグメンテーション

第9章 決定機構

第10章 市場成長牽引因子と課題

第11章 市場動向

第12章 ベンダー環境

  • 競合シナリオ

第13章 主要ベンダー分析

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic
  • 注目すべき企業
  • その他の有力なベンダー

第14章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR12450

About Coronary Stents

Coronary artery disease (CAD) or atherosclerotic heart disease is a type of heart disease that is associated with the hardening of the arteries due to the accumulation of fatty compounds, cholesterol, calcium, and other blood clotting materials in and around the artery wall. These lesions, if become unstable or clinically significant, are treated with PCI, which require balloon angioplasty and stent implantation. Coronary stents or cardiac stents are small, expandable tube-shaped devices made of stainless steel, which are placed in the artery for easy blood flow during the treatment of CAD.

Technavio's analysts forecast the global coronary stents market to grow at a CAGR of 5.61% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global coronary stents market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of coronary stents.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Coronary Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic

Other Prominent Vendors

  • Shandong JW Medical Systems
  • Biosensors International Group
  • Opto Circuits
  • Cook Medical
  • Elixir Medical
  • Envision Scientific
  • LEPU MEDICAL
  • Meril Life Sciences

Market driver

  • Increasing prevalence of cardiovascular disease (CVD) and government initiatives
  • For a full, detailed list, view our report

Market challenge

  • Stringent regulations for device approval
  • For a full, detailed list, view our report

Market trend

  • Emergence of digital catheterization laboratories in hospitals
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by products

  • DES
  • Bioresorbable stents
  • BMS

PART 07: Market segmentation by end-user

  • ASCs
  • Hospitals
  • Physicians' offices

PART 08: Geographical segmentation

  • Coronary stents market in Americas
  • Coronary stents market in EMEA
  • Coronary stents market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments

PART 11: Market trends

  • Growing adoption of hybrid procedure
  • Increasing partnerships and collaboration activities
  • Emergence of digital catheterization laboratories in hospitals

PART 12: Vendor landscape

  • Competitive landscape analysis

PART 13: Key vendor analysis

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic
  • Key companies to watch
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global coronary stents market: Impact assessment
  • Exhibit 02: Scope of coronary stents based on geography 2017-2021
  • Exhibit 03: Global coronary stents market 2016-2021 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global coronary stents market revenue by product in 2016-2021 ($ billions)
  • Exhibit 06: Market overview: DES
  • Exhibit 07: Global DES market 2016-2021 ($ billions)
  • Exhibit 08: Clinical studies: Comparison between DES and BMS
  • Exhibit 09: Market overview: Bioresorbable stents
  • Exhibit 10: Global bioresorbable stents market 2016-2021 ($ billions)
  • Exhibit 11: Clinical research on bioresorbable vascular scaffold by Abbott Laboratories
  • Exhibit 12: Clinical study: Bioresorbable stents compared with DES
  • Exhibit 13: Market overview: BMS
  • Exhibit 14: Global BMS market 2016-2021 ($ billions)
  • Exhibit 15: Global coronary stents market by end-users 2016
  • Exhibit 16: Reimbursement comparison for ASCs, hospital outpatient departments, and physicians' offices in US
  • Exhibit 17: Global coronary stents market by geography 2016-2021 ($ billions)
  • Exhibit 18: Coronary stents market in Americas 2016-2021 ($ billions)
  • Exhibit 19: Coronary stents market in Americas: Country-specific market analysis
  • Exhibit 20: Number of revascularization procedures in EMEA 2006 and 2013
  • Exhibit 21: Coronary stents market in EMEA 2016-2021 ($ billions)
  • Exhibit 22: Coronary stents market in EMEA: Country-specific market analysis
  • Exhibit 23: Coronary stents market in APAC 2016-2021 ($ billions)
  • Exhibit 24: Coronary stents market in APAC: Country-specific market analysis
  • Exhibit 25: Impact of drivers
  • Exhibit 26: Coronary stenting procedure: Cost components and prices
  • Exhibit 27: Impact of challenges
  • Exhibit 28: Clinical study for hybrid procedure
  • Exhibit 29: Market impact analysis: Mergers and acquisitions (M&A) and collaboration activities
  • Exhibit 30: Competitive structure analysis of global coronary stents market
  • Exhibit 31: Competitive landscape of global coronary stents market 2016
  • Exhibit 32: Strategies of large and small companies in global coronary stents market
  • Exhibit 33: Abbott Laboratories: Products
  • Exhibit 34: Abbott Laboratories: Key highlights
  • Exhibit 35: Abbott Laboratories: Strength assessment
  • Exhibit 36: Abbott Laboratories: Strategy assessment
  • Exhibit 37: Abbott Laboratories: Opportunity assessment
  • Exhibit 38: Boston Scientific: Products
  • Exhibit 39: Boston Scientific: Key highlights
  • Exhibit 40: Boston Scientific: Strength assessment
  • Exhibit 41: Boston Scientific: Strategy assessment
  • Exhibit 42: Boston Scientific: Opportunity assessment
  • Exhibit 43: Medtronic: Products
  • Exhibit 44: Medtronic: Key highlights
  • Exhibit 45: Medtronic: Strength assessment
  • Exhibit 46: Medtronic: Strategy assessment
  • Exhibit 47: Medtronic: Opportunity assessment
Back to Top